Results 91 to 100 of about 77,321 (327)

Assessing the Effect of Adalimumab in Granuloma Annulare: A Case Series and Literature Review

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Granuloma annulare (GA) is a benign granulomatous skin disorder for which standardized treatment guidelines are lacking due to limited evidence. Adalimumab, a TNF‐α inhibitor, shows promise as a therapeutic option due to its potential to disrupt GA granulomas.
Adriana Caixinha Valorenzos   +2 more
wiley   +1 more source

ABOUT GALEN (PAGES OF LIFE AND TRAITS OF THE PERSON IN THE ASSESSMENT OF THE DESCENDANTS)

open access: yesРазработка и регистрация лекарственных средств, 2019
The paper presents the pages of life and some character traits of the Roman physician Galen. The source of information is the materials published in domestic and foreign literature.
K. S. Guzev
doaj  

Dermatology [PDF]

open access: yes, 2004
Dermatology continues to develop at a steady pace. In the past few years there have been exciting advances in our understanding of skin structure and function in health and disease and progress in genetics, epidemiology, immunology, pharmacology and ...
Boffa, Michael J.
core   +1 more source

Juvenile Mycosis Fungoides: A Multicenter Retrospective Italian Study

open access: yesJEADV Clinical Practice, EarlyView.
This multicenter retrospective study included 29 juvenile mycosis fungoides (JMF) patients from five Italian centres with confirmed histopathological diagnosis. most often presents with hypopigmented/classic variants and CD8+ phenotype. Early‐onset cases ( < 14 years) show better long‐term outcomes.
Andrea Michelerio   +8 more
wiley   +1 more source

GALEN AND HIS KNOWLEDGE IN THE FIELD OF PHARMACOLOGY

open access: yesРазработка и регистрация лекарственных средств, 2019
The paper presents the literature data on the knowledge K. Galen in pharmacology. The source of information is the materials published in domestic and foreign literature.
K. S. Guzev
doaj  

Phase II evaluation of VDC-1101 in canine cutaneous T-cell lymphoma. [PDF]

open access: yes, 2014
BackgroundCanine cutaneous T-cell lymphoma (CTCL) is an uncommon disease for which efficacious therapies are lacking. The novel anticancer nucleotide prodrug VDC-1101 (formerly known as GS-9219) has shown efficacy in dogs with multicentric lymphoma.
Burgess, KE   +5 more
core   +2 more sources

GALEN AND KNOWLEDGE OF PHARMACY

open access: yesРазработка и регистрация лекарственных средств, 2019
The paper presents the literature data on the occurrence of the term "Galenic medicines" and the contribution of K. Galen in the formation and development of pharmacy.
K. S. Guzev
doaj  

Hyperhidrosis: problems and solutions [PDF]

open access: yesVestnik Dermatologii i Venerologii
The functional role of sweating is not limited only to thermoregulation and excretion. There are other functions of it — the ability to enhance and maintain hydration and barrier function of the skin.
Stanislava Yu. Petrova   +2 more
doaj   +1 more source

Long-term safety and efficacy of trifarotene 50 μg/g cream, a first-in-class RAR-γ selective topical retinoid, in patients with moderate facial and truncal acne. [PDF]

open access: yes, 2020
BackgroundTreatment for both facial and truncal acne has not sufficiently been studied.ObjectivesTo evaluate the long-term safety and efficacy of trifarotene in both facial and truncal acne.MethodsIn a multicentre, open-label, 52-week study, patients ...
Ahmad, F   +11 more
core  

Isotretinoin and Hidradenitis Suppurativa a Conflictual Binomial: Investigation on Differential Response Rate Between Inflammatory and Follicular Phenotype

open access: yesJEADV Clinical Practice, EarlyView.
A cohort of 21 HS patients treated with isotretinoin was enrolled in this study. The main outcome was HISCR50 achievement at week 16. Overall, 2/12 patients affected by follicular phenotype of HS and 2/9 patients affected by inflammatory phenotype of HS achieved HISCR50 at week 16. No significant difference was found in response to isotretinoin between
Maria Vittoria Cannizzaro   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy